中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
19期
20-20,22
,共2页
稳定性心绞痛%糖耐量异常%阿卡波糖
穩定性心絞痛%糖耐量異常%阿卡波糖
은정성심교통%당내량이상%아잡파당
Stable angina pectoris%Abnormal glucose tolerance%Acarbose
目的：探讨稳定性心绞痛合并糖耐量异常行阿卡波糖治疗的临床效果。方法：收治稳定性心绞痛合并糖耐量异常患者120例，随机分为观察组和对照组，各60例，观察组给予阿卡波糖治疗，对照组给予常规治疗，疗程3～4年。结果：观察组心绞痛临床改善情况明显优于对照组(P＜0.05)。观察组在治疗过程中，患者出现不稳定性心绞痛、心肌梗死、心力衰竭、心源性猝死以及糖尿病情况的发生率明显低于对照组(P＜0.05)。结论：稳定性心绞痛合并糖耐量异常行阿卡波糖治疗可显著改善预后，能够降低心血管事件的发生率，降低糖耐量异常向糖尿病转化率。
目的：探討穩定性心絞痛閤併糖耐量異常行阿卡波糖治療的臨床效果。方法：收治穩定性心絞痛閤併糖耐量異常患者120例，隨機分為觀察組和對照組，各60例，觀察組給予阿卡波糖治療，對照組給予常規治療，療程3～4年。結果：觀察組心絞痛臨床改善情況明顯優于對照組(P＜0.05)。觀察組在治療過程中，患者齣現不穩定性心絞痛、心肌梗死、心力衰竭、心源性猝死以及糖尿病情況的髮生率明顯低于對照組(P＜0.05)。結論：穩定性心絞痛閤併糖耐量異常行阿卡波糖治療可顯著改善預後，能夠降低心血管事件的髮生率，降低糖耐量異常嚮糖尿病轉化率。
목적：탐토은정성심교통합병당내량이상행아잡파당치료적림상효과。방법：수치은정성심교통합병당내량이상환자120례，수궤분위관찰조화대조조，각60례，관찰조급여아잡파당치료，대조조급여상규치료，료정3～4년。결과：관찰조심교통림상개선정황명현우우대조조(P＜0.05)。관찰조재치료과정중，환자출현불은정성심교통、심기경사、심력쇠갈、심원성졸사이급당뇨병정황적발생솔명현저우대조조(P＜0.05)。결론：은정성심교통합병당내량이상행아잡파당치료가현저개선예후，능구강저심혈관사건적발생솔，강저당내량이상향당뇨병전화솔。
Objective:To investigate the Clinical effect of acarbose in the treatment of stable angina combine with pectoris sugar tolerance anomaly.Methods:120 patients with stable angina combine with pectoris sugar tolerance anomaly were selected.They were randomly divided into the observation group and the control group with 60 cases in each group.The observation group were given acarbose treatment,while the control group was given conventional treatment.They were treated for 3~4 years.Results:The angina pectoris clinical improvement of the observation group was significantly better than that of the control group(P<0.05).The observation group in the course of treatment,the patients occur unstable angina,myocardial infarction,heart failure,sudden cardiac death and diabetes incidence was significantly less than those of the control group(P<0.05).Conclusion:Acarbose in the treatment of stable angina combine with pectoris sugar tolerance anomaly can significantly improve the prognosis,it can reduce the incidence of cardiovascular events,and reduce the IGT to diabetes conversion rate.
